Anti-PD1 induced psoriasis
Published: 28 September 2020| Version 1 | DOI: 10.17632/m7w8sszs6y.1
Contributor:
Vasiliki Nikolaou
Description
This table includes data from 115 patients who developed psoriasis as an immune related adverse event to anti-PD-1/PDL1 agents. Psoriasis treatment outcomes of both topical and systemic agents used are presented
Files
Categories
Dermatology, Psoriasis, Immune Checkpoint Blockade